Scott Hampton

• Directed and led projects leading to over thirty 510(k), PMA, and NDA approvals in drug delivery, ophthomalogy, dental, cosmetics, emergency medicine, obstetrics, oncology, and diabetes.

• Clients have included Intarcia, ElectroMedical Systems, Anteis, CIBA Vision, STAAR Surgical, Schwind Eye-Tech, Novartis, Clinton Health Initiative, Exsurco, Bill and Melinda Gates Foundation, Ophtha International, Solo Health, Glenveigh Medical, Duckworth & Kent, Helsinn Pharma, Myelotec, Norwood Eye-Care, and many other firms ranging from concept-phase startups through multinationals.

• Led brand licensing for Tropic Isle Living (2023), with terms satisfactory to the owners. Starting in January 2020, well before most business leaders were considering the possibility of a pandemic: solidified and then twice re-built supply chains, establishing direct imports, and rationalizing manufacturing. This allowed the company to grow retail distribution by a factor of five. Expanded the business to include contract manufacturing and white-label. Hired great people so that a smaller team could be more deliverable.

• Startups: $7.4 million raised in angel and seed rounds for USA and EU entrepreneurs.

• Various complex new factory or new product line IQ/OQ/PQ/Ver/Val programs (brown and green field) with large and small teams.

• Patents USA Applications/Approved: 20160166701, 20100028328, 20090214619, 20070297986,

  20070265650, 20060110429, 20050288696, 20050197697, 20040002756, 20040260320,

  20040260227, 20040260321, 20040071787, 20040028680, 20020120331, 2002161433,

  7160264, 6712847 (additional international independent and coordinated patents)

• CV available on request